NEW YORK (GenomeWeb News) – BG Medicine today reported a 7 percent increase year over year in revenues for the fourth quarter.

The Waltham, Mass.-based firm said that revenues for the three months ended Dec. 31, 2013 totaled $1.15 million, up from $1.07 million a year ago and beating the average analyst estimate of $1.1 million. Product revenues, however, declined to $884,000 from $978,000 a year ago, a 10 percent drop. Service revenues were up 182 percent to $265,000 from $94,000 in Q4 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.